author-photo

Lizbeth Gallagher

Bristol-Myers Squibb

11

Papers

118

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Design and synthesis of a novel series of (1′S,2R,4′S)-3H-4′-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2′-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor

2017 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (3)
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists

2017 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (4)
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

2017 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (9)
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (25)
Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

2016 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (15)
Development of a high-throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay.

2016 Rapid Communications in Mass Spectrometry
Show All
- Source
- Cite
- Save
Citations (3)
Development of an LC-MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays.

2014 Journal of Chromatography B
Show All
- Source
- Cite
- Save
Citations (5)